CryoPort Systems
CYRXCYRX · Stock Price
Historical price data
Overview
CryoPort Systems is a mission-critical enabler for the life sciences industry, providing integrated, temperature-controlled supply chain solutions that de-risk the logistics of high-value, sensitive materials. The company has established itself as a trusted partner through its robust quality framework, including ISO 21973 certification and its unique practice of requalifying every shipper after every use, supporting over 650 clinical trials and 500,000+ shipments. Its strategy revolves around offering a comprehensive, end-to-end platform that consolidates fragmented supply chain services under a single vendor, thereby capturing greater value as the cell and gene therapy market expands from clinical to commercial scale.
Technology Platform
Integrated platform combining patented temperature-controlled shipping systems (cryogenic to refrigerated), real-time digital tracking via CryoPortal®, and proprietary Chain of Compliance® protocols for end-to-end supply chain visibility and risk mitigation.
Funding History
4Opportunities
Risk Factors
Competitive Landscape
Competes with broad logistics giants (FedEx, UPS) who lack deep specialization, and niche cold chain packers who lack an integrated platform. CryoPort's key advantages are its end-to-end service suite, proprietary technology, and unique quality protocols like requalifying every shipper after every use.
Company Timeline
Founded in Irvine, United States
Series C: $15.0M
Debt: $20.0M